The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 
MeSH Review

Hypertrophy, Right Ventricular

 
 
Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.
 

Disease relevance of Hypertrophy, Right Ventricular

 

High impact information on Hypertrophy, Right Ventricular

 

Chemical compound and disease context of Hypertrophy, Right Ventricular

 

Biological context of Hypertrophy, Right Ventricular

 

Anatomical context of Hypertrophy, Right Ventricular

 

Gene context of Hypertrophy, Right Ventricular

 

Analytical, diagnostic and therapeutic context of Hypertrophy, Right Ventricular

References

  1. Continuous inhalation of nitric oxide protects against development of pulmonary hypertension in chronically hypoxic rats. Kouyoumdjian, C., Adnot, S., Levame, M., Eddahibi, S., Bousbaa, H., Raffestin, B. J. Clin. Invest. (1994) [Pubmed]
  2. Relevance of blockade of cardiac and circulatory angiotensin-converting enzyme for the prevention of volume overload-induced cardiac hypertrophy. Ruzicka, M., Leenen, F.H. Circulation (1995) [Pubmed]
  3. Prolonged administration of L-arginine ameliorates chronic pulmonary hypertension and pulmonary vascular remodeling in rats. Mitani, Y., Maruyama, K., Sakurai, M. Circulation (1997) [Pubmed]
  4. Pulmonary vasodilatory action of endogenous atrial natriuretic factor in rats with hypoxic pulmonary hypertension. Effects of monoclonal atrial natriuretic factor antibody. Raffestin, B., Levame, M., Eddahibi, S., Viossat, I., Braquet, P., Chabrier, P.E., Cantin, M., Adnot, S. Circ. Res. (1992) [Pubmed]
  5. Simvastatin attenuates smooth muscle neointimal proliferation and pulmonary hypertension in rats. Nishimura, T., Faul, J.L., Berry, G.J., Vaszar, L.T., Qiu, D., Pearl, R.G., Kao, P.N. Am. J. Respir. Crit. Care Med. (2002) [Pubmed]
  6. A novel peptide CXCR ligand derived from extracellular matrix degradation during airway inflammation. Weathington, N.M., van Houwelingen, A.H., Noerager, B.D., Jackson, P.L., Kraneveld, A.D., Galin, F.S., Folkerts, G., Nijkamp, F.P., Blalock, J.E. Nat. Med. (2006) [Pubmed]
  7. Heterozygous deficiency of hypoxia-inducible factor-2alpha protects mice against pulmonary hypertension and right ventricular dysfunction during prolonged hypoxia. Brusselmans, K., Compernolle, V., Tjwa, M., Wiesener, M.S., Maxwell, P.H., Collen, D., Carmeliet, P. J. Clin. Invest. (2003) [Pubmed]
  8. Cardiac renin-angiotensin system in the hypertrophied heart. Iwai, N., Shimoike, H., Kinoshita, M. Circulation (1995) [Pubmed]
  9. High-dose calcium channel-blocking therapy for primary pulmonary hypertension: evidence for long-term reduction in pulmonary arterial pressure and regression of right ventricular hypertrophy. Rich, S., Brundage, B.H. Circulation (1987) [Pubmed]
  10. Morphometry of exercise-induced right ventricular hypertrophy in the rat. Anversa, P., Levicky, V., Beghi, C., McDonald, S.L., Kikkawa, Y. Circ. Res. (1983) [Pubmed]
  11. Intravenous prophylhexedrine (Benzedrex) abuse and sudden death. Anderson, R.J., Garza, H.R., Garriott, J.C., Dimaio, V. Am. J. Med. (1979) [Pubmed]
  12. The DD genotype of the angiotensin converting enzyme gene is negatively associated with right ventricular hypertrophy in male patients with chronic obstructive pulmonary disease. van Suylen, R.J., Wouters, E.F., Pennings, H.J., Cheriex, E.C., van Pol, P.E., Ambergen, A.W., Vermelis, A.M., Daemen, M.J. Am. J. Respir. Crit. Care Med. (1999) [Pubmed]
  13. Effect of dexfenfluramine treatment in rats exposed to acute and chronic hypoxia. Eddahibi, S., Raffestin, B., Launay, J.M., Sitbon, M., Adnot, S. Am. J. Respir. Crit. Care Med. (1998) [Pubmed]
  14. Sildenafil improves alveolar growth and pulmonary hypertension in hyperoxia-induced lung injury. Ladha, F., Bonnet, S., Eaton, F., Hashimoto, K., Korbutt, G., Thébaud, B. Am. J. Respir. Crit. Care Med. (2005) [Pubmed]
  15. Congenital erythropoietin over-expression causes "anti-pulmonary hypertensive" structural and functional changes in mice, both in normoxia and hypoxia. Weissmann, N., Manz, D., Buchspies, D., Keller, S., Mehling, T., Voswinckel, R., Quanz, K., Ghofrani, H.A., Schermuly, R.T., Fink, L., Seeger, W., Gassmann, M., Grimminger, F. Thromb. Haemost. (2005) [Pubmed]
  16. Reversal of pulmonary vascular remodelling following hypoxic exposure: no effect of infusion of atrial natriuretic factor and neutral endopeptidase inhibitor. Zhao, L., Hughes, J.M., Winter, R.J. Cardiovasc. Res. (1994) [Pubmed]
  17. The superoxide dismutase mimetic, tempol, blunts right ventricular hypertrophy in chronic hypoxic rats. Elmedal, B., de Dam, M.Y., Mulvany, M.J., Simonsen, U. Br. J. Pharmacol. (2004) [Pubmed]
  18. Gene expression in a swine model of right ventricular hypertrophy: intercellular adhesion molecule, vascular endothelial growth factor and plasminogen activators are upregulated during pressure overload. Carroll, S.M., Nimmo, L.E., Knoepfler, P.S., White, F.C., Bloor, C.M. J. Mol. Cell. Cardiol. (1995) [Pubmed]
  19. Downregulation and nuclear relocation of MLP during the progression of right ventricular hypertrophy induced by chronic pressure overload. Ecarnot-Laubriet, A., De Luca, K., Vandroux, D., Moisant, M., Bernard, C., Assem, M., Rochette, L., Teyssier, J.R. J. Mol. Cell. Cardiol. (2000) [Pubmed]
  20. Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice. Zhao, Y.Y., Liu, Y., Stan, R.V., Fan, L., Gu, Y., Dalton, N., Chu, P.H., Peterson, K., Ross, J., Chien, K.R. Proc. Natl. Acad. Sci. U.S.A. (2002) [Pubmed]
  21. Oxygen toxicity and restructuring of pulmonary arteries--a morphometric study. The response to 4 weeks' exposure to hyperoxia and return to breathing air. Jones, R., Zapol, W.M., Reid, L. Am. J. Pathol. (1985) [Pubmed]
  22. The effect of halothane on the sarcoplasmic reticulum in normal and right ventricular hypertrophy in rabbits. Rooke, G.A., Su, J.Y. Anesth. Analg. (1993) [Pubmed]
  23. Comparative age-related acute and chronic pulmonary oxygen tolerance in rats. Laudert, S., Thibeault, D.W., Rezaiekhaligh, M.M., Mabry, S.M., Huntrakoon, M. J. Appl. Physiol. (1994) [Pubmed]
  24. Effect of alpha-tocopherol on antioxidants, lipid peroxidation, and the incidence of pulmonary hypertension syndrome (ascites) in broilers. Bottje, W., Enkvetchakul, B., Moore, R., McNew, R. Poult. Sci. (1995) [Pubmed]
  25. Deletion of the eNOS gene has a greater impact on the pulmonary circulation of male than female mice. Miller, A.A., Hislop, A.A., Vallance, P.J., Haworth, S.G. Am. J. Physiol. Lung Cell Mol. Physiol. (2005) [Pubmed]
  26. Extracellular signal regulated kinase and SMAD signaling both mediate the angiotensin II driven progression towards overt heart failure in homozygous TGR(mRen2)27. Boer, R.A., Pokharel, S., Flesch, M., van Kampen, D.A., Suurmeijer, A.J., Boomsma, F., van Gilst, W.H., van Veldhuisen, D.J., Pinto, Y.M. J. Mol. Med. (2004) [Pubmed]
  27. Partial HIF-1alpha deficiency impairs pulmonary arterial myocyte electrophysiological responses to hypoxia. Shimoda, L.A., Manalo, D.J., Sham, J.S., Semenza, G.L., Sylvester, J.T. Am. J. Physiol. Lung Cell Mol. Physiol. (2001) [Pubmed]
  28. MR imaging of caveolin gene-specific alterations in right ventricular wall thickness. De Souza, A.P., Cohen, A.W., Park, D.S., Woodman, S.E., Tang, B., Gutstein, D.E., Factor, S.M., Tanowitz, H.B., Lisanti, M.P., Jelicks, L.A. Magnetic resonance imaging. (2005) [Pubmed]
  29. Left but not right cardiac hypertrophy in atrial natriuretic peptide receptor-deficient mice is prevented by angiotensin type 1 receptor antagonist losartan. Holtwick, R., Baba, H.A., Ehler, E., Risse, D., Vobeta, M., Gehrmann, J., Pierkes, M., Kuhn, M. J. Cardiovasc. Pharmacol. (2002) [Pubmed]
  30. Alteration of monocrotaline pyrrole-induced cardiopulmonary effects in rats by hydrallazine, dexamethasone or sulphinpyrazone. Hilliker, K.S., Roth, R.A. Br. J. Pharmacol. (1984) [Pubmed]
  31. Inhaled nitric oxide attenuates pulmonary hypertension and improves lung growth in infant rats after neonatal treatment with a VEGF receptor inhibitor. Tang, J.R., Markham, N.E., Lin, Y.J., McMurtry, I.F., Maxey, A., Kinsella, J.P., Abman, S.H. Am. J. Physiol. Lung Cell Mol. Physiol. (2004) [Pubmed]
  32. Left superior vena cava to left atrial communication diagnosed with radionuclide angiocardiography and with differential right to left shunting. Konstam, M.A., Levine, B.W., Strauss, H.W., McKusick, K.A. Am. J. Cardiol. (1979) [Pubmed]
  33. Effects of the endothelin ET(A) receptor antagonist, TA-0201, on pulmonary arteries isolated from hypoxic rats. Itoh, H., Yokochi, A., Yamauchi-Kohno, R., Maruyama, K. Eur. J. Pharmacol. (1999) [Pubmed]
  34. Effects of the vasopeptidase inhibitor omapatrilat on peri- and postmyocardial infarction in Zucker lean rats. Lapointe, N., Parker, T.G., Tsoporis, J.N., Nguyen, Q.T., Marcotte, F., Adam, A., Lou, I., Rouleau, J.L. The Canadian journal of cardiology. (2005) [Pubmed]
 
WikiGenes - Universities